From venom to drugs: a review and critical analysis of Indian snake venom toxins envisaged as anticancer drug prototypes
- 1 April 2021
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 26 (4), 993-1005
- https://doi.org/10.1016/j.drudis.2020.12.021
Abstract
No abstract availableThis publication has 103 references indexed in Scilit:
- From antimicrobial to anticancer peptides. A reviewFrontiers in Microbiology, 2013
- Assessment of the Evolution of Cancer Treatment TherapiesCancers, 2011
- Snakebite Mortality in India: A Nationally Representative Mortality SurveyPLoS Neglected Tropical Diseases, 2011
- Anti-apoptosis and cell survival: A reviewBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Natural Products as Chemical ProbesACS Chemical Biology, 2010
- Snake Bite in South Asia: A ReviewPLoS Neglected Tropical Diseases, 2010
- Inhibition of Cancer Cell Proliferation in vitro and Tumor Growth in vivo by Hydrophis spiralis Sea Snake VenomInternational Journal of Cancer Research, 2007
- The effect of anticoagulants on cancer risk and survival: Systematic reviewCancer Treatment Reviews, 2007
- Development of a Novel Recombinant Disintegrin, Contortrostatin, as an Effective Anti-Tumor and Anti-Angiogenic AgentPathophysiology of Haemostasis and Thrombosis, 2005
- Diet and snake venom evolutionNature, 1996